Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis
Claire E. J. Waterborg(Radboud University Nijmegen), Fons A. J. van de Loo(Radboud University Nijmegen)
Cited by 27
Related Papers
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis
|Annals of the Rheumatic Diseases|2015|93
Unraveling the roles of AXL and MER in models of rheumatoid arthritis. Aim for the stars
|Data Archiving and Networked Services (DANS)|2019|0